Mutations in the ANGPTL3 gene and familial combined hypolipidemia: a clinical and biochemical characterization. - Wikidata - awgldk - TriplyDB

Mutations in the ANGPTL3 gene and familial combined hypolipidemia: a clinical and biochemical characterization.

Mutations in the ANGPTL3 gene and familial combined hypolipidemia: a clinical and biochemical characterization.

http://www.wikidata.org/entity/Q33569939

about

The role of ANGPTL3 in controlling lipoprotein metabolism Silencing of ANGPTL 3 (angiopoietin-like protein 3) in human hepatocytes results in decreased expression of gluconeogenic genes and reduced triacylglycerol-rich VLDL secretion upon insulin stimulation.Hypobetalipoproteinemia and abetalipoproteinemia.Inactivation of ANGPTL3 reduces hepatic VLDL-triglyceride secretion.ANGPTL3 blockade with a human monoclonal antibody reduces plasma lipids in dyslipidemic mice and monkeys.What can we learn about lipoprotein metabolism and coronary heart disease from studying rare variants?Effects of angiopoietin-like protein 3 deficiency on postprandial lipid and lipoprotein metabolism.Inactivating Variants in ANGPTL4 and Risk of Coronary Artery Disease Clinical characteristics and plasma lipids in subjects with familial combined hypolipidemia: a pooled analysis.Development of Antisense Drugs for Dyslipidemia.Update on primary hypobetalipoproteinemia.ANGPTL3 Deficiency and Protection Against Coronary Artery Disease.ANGPLT3: A novel modulator of lipid metabolism.Antibodies to human angiopoietin-like protein 3: a patent evaluation of WO2012174178.Threshold Effects of Circulating Angiopoietin-Like 3 Levels on Plasma Lipoproteins.Tissue expression and predicted protein structures of the bovine ANGPTL3 and association of novel SNPs with growth and meat quality traits.Angiopoietin-like 3 in lipoprotein metabolism.Genetic and Pharmacologic Inactivation of ANGPTL3 and Cardiovascular Disease.Liraglutide protects cardiac function in diabetic rats through the PPARα pathway.Analysis of circulating angiopoietin-like protein 3 and genetic variants in lipid metabolism and liver health: the DiOGenes study.A Possible Mechanism: Vildagliptin Prevents Aortic Dysfunction through Paraoxonase and Angiopoietin-Like 3.

P2860

Q26769679-40C43E85-9871-4975-BC4E-7F2421E6549E Q34706796-A8C806C5-5F0C-4E99-9418-4A578ED0A9A8 Q35738368-6E0DCC0E-4D67-445A-8DE6-E1C7B4483807 Q35776630-E76AD374-50F5-4538-8F47-92B6FCA0EED7 Q35776636-C7344143-BEC5-450B-A5BD-941DA6EC72B5 Q36760799-0D231B6D-89AE-4305-A065-89669BA21784 Q36930209-D3C7337B-F6C6-4DAF-B54A-46E395B9BF1F Q36988623-A77019DF-C3A4-48FE-BD85-28D5C8A621F5 Q37305417-899C23BA-719D-4B0B-B36E-C3202BACC74E Q37387192-4A308241-1D8F-4320-9C7C-70C494A0A96E Q38208223-948DF8E0-D5AE-4B2B-BB47-589AD14CDA6A Q40254292-27887256-8CE4-48E0-AB11-F3D630316375 Q42367565-D0EF1C60-9405-4F35-A2E3-DD9DC2B0FA2F Q44239582-260A8848-D03D-47D3-B3AB-CFE2D5BA9C13 Q46347201-E8E1C0DE-C1AB-47B3-93B6-CF4D27A32E4A Q46731705-F5436174-6675-481B-92DA-B8BA73EA8CDB Q47688043-8D9FEFE2-9D19-4D8A-B1E4-A8A4F3335767 Q47877816-AE56F9DF-6D5A-4FDF-8A8C-98706E3F814C Q50026330-188C46E6-54FB-4975-B878-3F39073AB071 Q55128897-43A6D61B-07E6-4145-A677-6ECBACE596D4 Q55382850-E1D12154-876D-4A22-B5CC-75AD3904B667

P2860

Mutations in the ANGPTL3 gene and familial combined hypolipidemia: a clinical and biochemical characterization.

http://www.wikidata.org/entity/Q33569939

description

2012 nî lūn-bûn

@nan

2012 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Mutations in the ANGPTL3 gene ...... biochemical characterization.

@ast

Mutations in the ANGPTL3 gene ...... biochemical characterization.

@en

Mutations in the ANGPTL3 gene ...... biochemical characterization.

@nl

type

label

Mutations in the ANGPTL3 gene ...... biochemical characterization.

@ast

Mutations in the ANGPTL3 gene ...... biochemical characterization.

@en

Mutations in the ANGPTL3 gene ...... biochemical characterization.

@nl

prefLabel

Mutations in the ANGPTL3 gene ...... biochemical characterization.

@ast

Mutations in the ANGPTL3 gene ...... biochemical characterization.

@en

Mutations in the ANGPTL3 gene ...... biochemical characterization.

@nl

P1433

Q33569939-1C08E48E-B465-42BD-862D-C20BC661AFEE

P1476

Q33569939-8C34A42A-3200-4998-9E21-919D27686FE5

P2093

Q33569939-03122057-D954-4FEE-A823-E82989D46F16

Q33569939-3787D362-8D91-4053-84C4-CEBFE621EB1F

Q33569939-39CE35B1-6C7A-48D9-85B4-E5730E0E65C7

Q33569939-3BE412F7-D79F-4DCF-A93F-E965A7D93B25

Q33569939-72562843-42AC-403F-A86A-30A822EB86D2

Q33569939-77457F05-48A3-486D-9301-55E7AF2DE94E

Q33569939-7E6B431E-4ADC-4E94-B643-D0794C222F1F

Q33569939-8E714604-BF68-4973-AFBB-CAEC1E4FBF77

Q33569939-A6AEF9D1-368D-4248-9955-2EDE7E168FEB

Q33569939-D1D91C17-CC1C-454D-B904-DE8B0C7F2046

P2860

Q33569939-0535282E-D1A6-480F-B53F-C83DA98E8596

Q33569939-0BE1FE4F-8768-435A-9416-C67A754D4F24

Q33569939-1109F80A-175B-4A97-9F92-FE22BF8B90BE

Q33569939-131D857D-1D3A-4DC6-8E91-3E43C1FA0974

Q33569939-1783A361-EC64-4AFB-B655-2CF346496B57

Q33569939-2070F7CE-D431-446B-8393-62B9C4825DE1

Q33569939-24849E30-34E6-4ED3-ADCE-BB1B9B9A561F

Q33569939-2FBAB009-F277-491B-B5F2-7F00412FF4DB

Q33569939-3735469C-40ED-4FEA-805A-05E9A84BCE9E

Q33569939-4FFA5E32-9598-43EB-8AD4-CBBED4D49E11

P304

Q33569939-2F5624C2-AAEB-41ED-B0BC-D41AEDCC6D2D

P31

Q33569939-CA2F6AE1-A8A1-43B9-B5FA-78395D57B358

P356

Q33569939-79F873F9-457D-44A6-8737-50569FB222AC

P407

Q33569939-9E0EBF84-E3B3-456A-8120-FB13F1575E7E

P433

Q33569939-9B29D3E2-B602-457B-BA1A-FD07D55DE46D

P478

Q33569939-0C47219B-B74E-4321-B2EE-80AFA17BD70D

P50

Q33569939-44DE2C5A-D54F-4297-BDE0-FF50F7F2AEA2

Q33569939-649546F6-96B2-4F7C-9DE7-1E3F82EA3B7C

Q33569939-E685B534-14C6-4238-94A5-35788635E940

P577

Q33569939-CA5089C5-A107-40C1-B32D-3C78F9A6AF1A

P698

Q33569939-3D1F1B5F-1432-4DB5-AE7A-E98E5D4FA8E3

P932

Q33569939-F981A16E-0CDD-43A1-A632-58F59CDCCEC3

P356

P1433

The Journal of Clinical Endocrinology and Metabolism

P1476

Mutations in the ANGPTL3 gene ...... biochemical characterization.

@en

P2093

Anna Montali

http://www.w3.org/2001/XMLSchema#string

Christian Ehnholm

http://www.w3.org/2001/XMLSchema#string

Claudia Gabiati

http://www.w3.org/2001/XMLSchema#string

Dieter Lütjohann

http://www.w3.org/2001/XMLSchema#string

Fabio Pannozzo

http://www.w3.org/2001/XMLSchema#string

Giancarlo Labbadia

http://www.w3.org/2001/XMLSchema#string

Giovanni Pigna

http://www.w3.org/2001/XMLSchema#string

Marcello Arca

http://www.w3.org/2001/XMLSchema#string

Maria Laura Sepe

http://www.w3.org/2001/XMLSchema#string

Marius Robert Robciuc

http://www.w3.org/2001/XMLSchema#string

P2860

Annexin A2 is a C-terminal PCSK9-binding protein that regulates endogenous low density lipoprotein receptor levels

Angiopoietin-like protein3 regulates plasma HDL cholesterol through suppression of endothelial lipase

Biological, clinical and population relevance of 95 loci for blood lipids

Report of the Conference on Low Blood Cholesterol: Mortality Associations

Familial hypobetalipoproteinemia: genetics and metabolism

Exome sequencing, ANGPTL3 mutations, and familial combined hypolipidemia

ANGPTL3 decreases very low density lipoprotein triglyceride clearance by inhibition of lipoprotein lipase

A decreased expression of angiopoietin-like 3 is protective against atherosclerosis in apoE-deficient mice

Quantitation of serum angiopoietin-like proteins 3 and 4 in a Finnish population sample

Low LDL cholesterol in individuals of African descent resulting from frequent nonsense mutations in PCSK9.

P304

E1266-75

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1210/JC.2012-1298

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

97

http://www.w3.org/2001/XMLSchema#string

P50

Ilenia Minicocci

Fabiana Quagliarini

Matti Jauhiainen

P577

2012-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22659251

http://www.w3.org/2001/XMLSchema#string

P932

5393441

http://www.w3.org/2001/XMLSchema#string